Patrick J. Langlois
Direktor/Vorstandsmitglied bei NEWRON PHARMACEUTICALS S.P.A.
Profil
Patrick J.
Langlois is currently the Chairman at ArkAb SAS, Independent Non-Executive Director at Newron Pharmaceuticals SpA, General Partner at PJL Consulting, and General Partner at DFC Langlois.
Previously, he served as Non-Executive Chairman at Stallergenes SA, Chairman at Valerio Therapeutics SA, Vice Chairman-Supervisory Board at Exonhit, Independent Chairman at Sensorion SA, Chairman at B Cell Design SAS, Vice Chairman-Supervisory Board at Eurobio-Scientific SA, Vice Chairman at Stallergenes Greer Ltd., Director at Shire Plc, Coley Pharmaceutical Group, Inc., and Shire Acquisition, Inc., Independent Director at SCYNEXIS, Inc., Director at Curium PET France, Chief Financial Officer & Group Executive VP at Aventis SA, and Chief Financial Officer at Rhone-Poulenc Rorer, Inc. He is also an Independent Member-Supervisory Board at Innate Pharma SA. He holds a doctorate and undergraduate degree from the University of Rennes.
Aktive Positionen von Patrick J. Langlois
Unternehmen | Position | Beginn |
---|---|---|
NEWRON PHARMACEUTICALS S.P.A. | Direktor/Vorstandsmitglied | 01.01.2008 |
DFC Langlois | Corporate Officer/Principal | - |
PJL Consulting
PJL Consulting Miscellaneous Commercial ServicesCommercial Services PJL Consulting provides business and management consulting services. | Corporate Officer/Principal | 01.02.2005 |
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Vorsitzender | 13.01.2018 |
Ehemalige bekannte Positionen von Patrick J. Langlois
Unternehmen | Position | Ende |
---|---|---|
INNATE PHARMA | Direktor/Vorstandsmitglied | 20.05.2022 |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Vorsitzender | 01.01.2021 |
SENSORION | Vorsitzender | 05.07.2020 |
STALLERGENES GREER | Direktor/Vorstandsmitglied | 07.06.2018 |
VALERIO THERAPEUTICS | Vorsitzender | 31.01.2016 |
Ausbildung von Patrick J. Langlois
University of Rennes | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 7 |
---|---|
SCYNEXIS, INC. | Health Technology |
VALERIO THERAPEUTICS | Health Technology |
NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
INNATE PHARMA | Health Technology |
NANOBIOTIX | Health Technology |
SENSORION | Health Technology |
EUROBIO SCIENTIFIC | Health Technology |
Private Unternehmen | 15 |
---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Aventis SA
Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is the researching, development and marketing of prescription medicines. The Group operations focuses on three therapeutic areas - central nervous system disorders, gastrointestinal and renal diseases. The Group's marketed products for such disorders include ADDERALL and ADDERALL XR, for attention deficit hyperactivity disorder, REMINYL for Alzheimer's, co-marketed with Johnson and Johnson and CARBATROL. for epilepsy. The Group is also developing a range of treatments for ADHD which may treat children, adolescents and adults extending the use of its current brand as well as researching non-scheduled compounds. The Group operates in the United Kingdom, the United States of America, France, Germany, Italy, Spain, Ireland, Canada, the Netherlands and the Cayman Islands. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Stallergenes SA
Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | Health Technology |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Curium PET France
Curium PET France Miscellaneous Commercial ServicesCommercial Services Laboratoires Cyclopharma SA manufactures pharmaceutical preparations. The company is headquartered in Saint-Beauzire, France. | Commercial Services |
PJL Consulting
PJL Consulting Miscellaneous Commercial ServicesCommercial Services PJL Consulting provides business and management consulting services. | Commercial Services |
DFC Langlois | |
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Health Technology |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Commercial Services |
Stallergenes Greer Ltd.
Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |